Skip to main content

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
GOLDMAN SACHS GROUP INC UWMC UWM Holdings Corp 13G/A 2.6% 3d
STATE STREET CORP PKE Park Aerospace Corp 13G 4.7% 3d
STATE STREET CORP HIW Highwoods Properties, Inc. 13G 7.1% 3d
STATE STREET CORP NVAX Novavax Inc 13G 5.4% 3d
STATE STREET CORP IDR Idaho Strategic Resources, Inc. 13G 5.9% 3d
Hudson Bay Capital Management LP MESH Meshflow Acquisition Corp 13G/A 4.29% 3d
GOLDMAN SACHS GROUP INC OTAI Starlink AI Acquisition Corp 13G 6.1% 3d
STATE STREET CORP IOVA Iovance Biotherapeutics, Inc. 13G 4.8% 3d
STATE STREET CORP AVTX Avalo Therapeutics, Inc. 13G 4.8% 3d
First Eagle Investment Management, LLC WTW Willis Towers Watson PLC 13G 5% 3d
Wang Guanran FOIL Londian Wason New Energy Tech Inc. 13G 50.9% 3d
STATE STREET CORP REPL Replimune Group, Inc. 13G 4.4% 3d
STATE STREET CORP USAR USA Rare Earth, Inc. 13G 3.8% 3d
STATE STREET CORP FIS Fidelity National Information Services, Inc. 13G 5.4% 3d
STATE STREET CORP CTGO Contango Silver & Gold Inc. 13G 5.1% 3d
STATE STREET CORP DGX Quest Diagnostics Inc 13G 5% 3d
STATE STREET CORP RGNX REGENXBIO Inc. 13G 4.8% 3d
LSV ASSET MANAGEMENT GDRX GoodRx Holdings, Inc. 13G 5.5% 3d
STATE STREET CORP SRPT Sarepta Therapeutics, Inc. 13G 7% 3d
STATE STREET CORP UVV Universal Corp 13G 6% 3d
Invesco Ltd. ITGR Integer Holdings Corp 13G/A 0.4% 3d
Invesco Ltd. USAC USA Compression Partners, LP 13G/A 11.1% 3d
STATE STREET CORP VERA Vera Therapeutics, Inc. 13G 4.6% 3d
Invesco Ltd. ESE Esco Technologies Inc 13G/A 4.6% 3d
Mitchell P. Kopin BJDX Bluejay Diagnostics, Inc. 13G/A 4.99% 3d
STATE STREET CORP LEU Centrus Energy Corp 13G 7.4% 3d
STATE STREET CORP TRMB Trimble Inc. 13G 4% 3d
STATE STREET CORP DK Delek US Holdings, Inc. 13G 6.3% 3d
Mitchell P. Kopin BBLG Bone Biologics Corp 13G/A 9.99% 3d
Magnolia Capital Fund, LP PCYO Pure Cycle Corp 13G/A 4% 3d
STATE STREET CORP MNKD Mannkind Corp 13G 4.7% 3d
Connor, Clark & Lunn Investment Management Ltd. EFXT Enerflex Ltd. 13G/A 9.2% 3d
GOLDMAN SACHS GROUP INC LAFA LaFayette Acquisition Corp. 13G/A 7.5% 3d
Invesco Ltd. COLL Collegium Pharmaceutical, Inc 13G/A 3.9% 3d
STATE STREET CORP CMPX Compass Therapeutics, Inc. 13G 4.3% 3d
Mitchell P. Kopin PPBT Purple Biotech Ltd. 13G/A 9.99% 3d
Invesco Ltd. PARR Par Pacific Holdings, Inc. 13G/A 5% 3d
STATE STREET CORP PRGS Progress Software Corp 13G 5.1% 3d
STATE STREET CORP ADMA Adma Biologics, Inc. 13G 6.1% 3d
STATE STREET CORP TWST Twist Bioscience Corp 13G 4.6% 3d
STATE STREET CORP KOPN Kopin Corp 13G 7.3% 3d
STATE STREET CORP OKE Oneok Inc 13G 6.6% 3d
GOLDMAN SACHS GROUP INC DAAQ Digital Asset Acquisition Corp. 13G 5.6% 3d
CONNORS KATHLEEN MARIE OESX Orion Energy Systems, Inc. 13G/A 4% 3d
STATE STREET CORP TKO TKO Group Holdings, Inc. 13G 5% 3d
LSV ASSET MANAGEMENT DIN Dine Brands Global, Inc. 13G 5% 3d
STATE STREET CORP CSCO Cisco Systems, Inc. 13G 5% 3d
Invesco Ltd. FINV FinVolution Group 13G 8.1% 3d
Bleichroeder LP MODD Modular Medical, Inc. 13G/A 4.99% 3d
STATE STREET CORP CRVS Corvus Pharmaceuticals, Inc. 13G 4% 3d